A leading pharmaceuticals manufacturing company was looking for Regulatory support in PDE evaluation of established medicinal products. The lack of document and toxicological information acted as an obstacle for the conduction of studies. Freyr supported the client by streamlining the evaluation process and conducting the studies on time.

To know more about how Freyr managed to perform 250 PDE evaluation under stringent timeline, download the case study.

Download